Recent Updates
Recently added Catalysts
IDYA

IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP Deletion Urothelial and Lung Cancer on Monday, July 8, 2024

Friday, July 5, 2024 1 min read
Key Takeaway: IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP Deletion Urothelial and Lung Cancer on Monday, July 8, 2024

Full Press Release Details

IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP Deletion Urothelial and Lung Cancer on Monday, July 8, 2024.
Tags: IDYA Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jul 5, 2024